Large pharmaceutical companies such as Pfizer and Sanofi are investing in the supplement category, a potential growth opportunity for pharmaceuticals. This category, once ignored by pharmaceutical companies, is almost as large as over-the-counter medication in terms of global retail sales. Chris Schmidt, Consumer Health Company Analyst at Euromonitor, cites several key areas of M&A activity in consumer health.
Introducing Opportunity Minded, a new series from Euromonitor International designed for forward-thinking business leaders like you. Each episode tackles a strategic approach or topic on corporate agendas. You’ll hear from our experts who share in
